Literature DB >> 1407011

M1 muscarinic receptors mediate intracellular calcium release in NB-OK1 human neuroblastoma cells.

H W Boddeke1, M Buttini, M Lichtsteiner, A Enz.   

Abstract

Muscarine acetylcholine receptors were characterized in NB-OK1 cells using radioligand (3H-NMS) binding experiments and second messenger (calcium and phosphatidylinositol (PI) turnover) studies. In radioligand binding experiments the displacement curves of pirenzepine (KI = 1.3 x 10(-8) M), AF-DX 116 (KI = 8.2 x 10(-7) M), methoctramine (KI = 8.4 x 10(-8) M) and parafluorohexahydrosiladifenidol (pF-HHSiD) (KI = 1.8 x 10(-8) M) were monophasic and indicated the presence of M1 muscarinic receptors. Schild analysis with the muscarinic antagonists pirenzepine, AF-DX 116, methoctramine and pF-HHSiD yielded pA2 values of 8.40 +/- 0.13, 6.48 +/- 0.09, 7.61 +/- 0.12 and 7.22 +/- 0.08 in the calcium experiments and pA2 values of 8.13 +/- 0.30 and 6.26 +/- 0.26, 7.65 +/- 0.16 and 7.46 +/- 0.11, respectively, in the PI turnover experiments. These results indicate that both the carbachol-induced increase in intracellular calcium and the increase in PI turnover are mediated by M1 muscarinic receptors. In calcium free buffer, stimulation with carbachol induced similar responses to those seen under control conditions. From functional and radioligand binding experiments we conclude that the muscarinic receptor expressed in NB-OK1 cells is the M1 subtype. In addition, the M1 receptor-induced calcium response is related to PI turnover and is independent on extracellular calcium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407011     DOI: 10.1007/bf00173537

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

1.  80% of muscarinic receptors expressed by the NB-OK 1 human neuroblastoma cell line show high affinity for pirenzepine and are comparable to rat hippocampus M1 receptors.

Authors:  M Waelbroeck; J Camus; M Tastenoy; J Christophe
Journal:  FEBS Lett       Date:  1988-01-04       Impact factor: 4.124

2.  Depolarization of human neuroblastoma cells as a result of muscarinic receptor-induced rise in cytosolic Ca2+.

Authors:  K E Akerman
Journal:  FEBS Lett       Date:  1989-01-02       Impact factor: 4.124

Review 3.  The molecular basis of muscarinic receptor diversity.

Authors:  T I Bonner
Journal:  Trends Neurosci       Date:  1989-04       Impact factor: 13.837

4.  Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor.

Authors:  T Kubo; K Fukuda; A Mikami; A Maeda; H Takahashi; M Mishina; T Haga; K Haga; A Ichiyama; K Kangawa
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

Review 5.  Inositol trisphosphate and diacylglycerol: two interacting second messengers.

Authors:  M J Berridge
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

6.  Affinity spectra: a novel way for the evaluation of equilibrium binding experiments.

Authors:  H J Tobler; G Engel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-04       Impact factor: 3.000

7.  Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.

Authors:  M Waelbroeck; M Gillard; P Robberecht; J Christophe
Journal:  Mol Pharmacol       Date:  1986-10       Impact factor: 4.436

8.  Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate.

Authors:  H Streb; R F Irvine; M J Berridge; I Schulz
Journal:  Nature       Date:  1983 Nov 3-9       Impact factor: 49.962

9.  Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Authors:  F Dörje; J Wess; G Lambrecht; R Tacke; E Mutschler; M R Brann
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

10.  Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors.

Authors:  E G Peralta; A Ashkenazi; J W Winslow; D H Smith; J Ramachandran; D J Capon
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.